MarkJacobSiednerMD
Infectious Disease • Boston, MAResearch Fellow in Medicine, Massachusetts General Hospital
Are you Dr. Siedner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Massachusetts General Hospital Grj504
Boston, MA 02114Phone+1 617-726-3812Fax+1 617-726-7416
Summary
- Dr. Mark Siedner, MD is an infectious disease specialist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and New York. He is affiliated with Massachusetts General Hospital and is a Research Fellow in Medicine at Massachusetts General Hospital.
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2010 - 2012
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2007 - 2010
Johns Hopkins University School of MedicineClass of 2007
Certifications & Licensure
MA State Medical License 2012 - 2026
NY State Medical License 2008 - 2010- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda Start of enrollment: 2012 Jul 01
- Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa Start of enrollment: 2019 May 14
Publications & Presentations
PubMed
- 4 citationsThe long wait for long-acting HIV prevention and treatment formulations.Willem Daniel Francois Venter, Monica Gandhi, Simiso Sokhela, Kenly Sikwese, Helen Bygrave
The Lancet. HIV. 2024-10-01 - 1 citationsUntangling the causal ties between antiretrovirals and obesity.Jennifer Manne-Goehler, Mark J Siedner
The Lancet. HIV. 2024-10-01 - Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results.Suzanne M McCluskey, Winnie R Muyindike, Victoria Nanfuka, Daniel Omoding, Nimusiima Komukama
The Journal of Infectious Diseases. 2024-09-23
Authored Content
- How to Spot Good Covid-19 Vaccine Trials Results When You See ThemNovember 2020
Press Mentions
Five Things About Covid We Still Don’t Understand at Our PerilSeptember 26th, 2022- New Case of Polio Diagnosed in New York, Poliovirus Found in Wastewater in Two CountiesAugust 26th, 2022
- How Reasonable Are the CDC’s Recent Changes to COVID Guidelines?August 16th, 2022
- Join now to see all
